Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome

被引：9

作者：

Amemiya, Nobuyuki ^{[1
]}

Takei, Takashi ^{[1
]}

Kojima, Chiari ^{[1
]}

Nokiba, Hirohiko ^{[1
]}

Itabashi, Mitsuyo ^{[1
]}

Nitta, Kosaku ^{[1
]}

机构：

[1] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Tokyo 1628666, Japan

来源：

CLINICAL AND EXPERIMENTAL NEPHROLOGY | 2011年 / 15卷 / 06期

关键词：

Frequently relapsing minimal change nephrotic syndrome; Rituximab; Monotherapy; THERAPY; RELAPSE;

D O I：

10.1007/s10157-011-0510-5

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Treatment with a single dose of rituximab alone induced remission in a patient with relapsed minimal change nephrotic syndrome (MCNS). A 27-year-old man was given corticosteroid (prednisolone; PSL) and cyclosporine (CyA) therapy combined with rituximab for his fifth relapse in 2008. Thereafter, complete remission was achieved and maintained despite eventual discontinuation of the PSL and CyA. In 2010, we treated his sixth relapse with a single dose of rituximab. Complete remission was obtained 32 days later. This is the first report of rituximab monotherapy in the treatment of MCNS.

引用

页码：933 / 936

页数：4

共 11 条

[1] Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy [J].

Benz, K ;

Dötsch, J ;

Rascher, W ;

Stachel, D .

PEDIATRIC NEPHROLOGY, 2004, 19 (07) :794-797

[2] T cells and minimal change disease [J].

Cunard, R ;

Kelly, CJ .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05)

[3] Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult:: First case report and pathophysiological considerations [J].

Francois, Helene ;

Daugas, Eric ;

Bensman, Albert ;

Ronco, Pierre .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (01) :158-161

[4] Rituximab therapy for steroid-dependent minimal change nephrotic syndrome [J].

Gilbert, Rodney D. ;

Hulse, Eleanor ;

Rigden, Susan .

PEDIATRIC NEPHROLOGY, 2006, 21 (11) :1698-1700

[5] Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases [J].

Guigonis, Vincent ;

Dallocchio, Aymeric ;

Baudouin, Veronique ;

Dehennault, Maud ;

Camus, Caroline Hachon-Le ;

Afanetti, Mickael ;

Groothoff, Jaap ;

Llanas, Brigitte ;

Niaudet, Patrick ;

Nivet, Hubert ;

Raynaud, Natacha ;

Taque, Sophie ;

Ronco, Pierre ;

Bouissou, Francois .

PEDIATRIC NEPHROLOGY, 2008, 23 (08) :1269-1279

[6] Hypothesis: Dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide [J].

Johnson, RJ ;

Hurtado, A ;

Merszei, J ;

Rodriguez-Iturbe, B ;

Feng, LL .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (03) :575-581

[7] T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome [J].

Mansour, H ;

Cheval, L ;

Elalouf, JM ;

Aude, JC ;

Alyanakian, MA ;

Mougenot, B ;

Doucet, A ;

Deschênes, G .

KIDNEY INTERNATIONAL, 2005, 67 (06) :2168-2177

[8] Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment [J].

Pescovitz, MD ;

Book, BK ;

Sidner, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (18) :1961-1963

[9]

Sawara Y, 2009, CLIN NEPHROL, V72, P69

[10] Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? [J].

Smith, Graham C. .

PEDIATRIC NEPHROLOGY, 2007, 22 (06) :893-898

← 1 2 →